Stocktoria
ENDONOVO THERAPEUTICS, INC. ENDV
OTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2012-03-09
ENDONOVO THERAPEUTICS, INC. (ENDV) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2022 revenue was $135,355 at a -13649.2% net margin.
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$0M
Net margin-13649.2%
Revenue trend · last 8y · up
How it ranks in Manufacturing · percentile among 1906 companies
Piotroski Fstronger than 27%
Net marginstronger than 3%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ENDV | ENDONOVO THERAPEUTICS, INC. | 3/9 | — | — | — |
| VANI | Vivani Medical, Inc. | 1/9 | -14.41 | — | — |
| NXL | Nexalin Technology, Inc. | 4/9 | — | — | — |
| POSC | POSITRON CORP | 2/9 | — | — | — |
| ITOC | iTonic Holdings Ltd | 1/9 | 5.57 | — | — |
| GTHP | GUIDED THERAPEUTICS INC | 3/9 | — | — | — |
| HCIL | Hongchang International Co., Ltd | 2/9 | 2.23 | — | — |
FAQ
Is ENDV financially healthy?
ENDONOVO THERAPEUTICS, INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does ENDV pay a dividend?
No, ENDONOVO THERAPEUTICS, INC. does not currently pay a dividend.
How profitable is ENDV?
In FY2022, ENDONOVO THERAPEUTICS, INC. had a net margin of -13649.2%.
Source: SEC EDGAR filings · CIK 0001528172 · US · as of 2022-12-31. facts plus Stocktoria's own computed scores — not investment advice.